Meta's Brain2Qwerty: Non-Invasive Brain-Computer Interface Achieves Text Translation from Brain Signals
Meta's Brain2Qwerty, a non-invasive brain-computer interface tested on 35 volunteers in Spain, translates brain signals into text with varying accuracy depending on the imaging technology used (MEG achieving 32% CER, EEG 67%), showcasing a potential leap forward in assistive communication.
Meta's Brain2Qwerty: Non-Invasive Brain-Computer Interface Achieves Text Translation from Brain Signals
Meta's Brain2Qwerty, a non-invasive brain-computer interface tested on 35 volunteers in Spain, translates brain signals into text with varying accuracy depending on the imaging technology used (MEG achieving 32% CER, EEG 67%), showcasing a potential leap forward in assistive communication.
Progress
36% Bias Score
Neuralink's Brain Implants Show Promise, but Safety Concerns Remain
Elon Musk's Neuralink has implanted its brain-computer interface in three people, with two showing restored functionality; the company plans to expand trials, yet safety and regulatory hurdles remain.
Neuralink's Brain Implants Show Promise, but Safety Concerns Remain
Elon Musk's Neuralink has implanted its brain-computer interface in three people, with two showing restored functionality; the company plans to expand trials, yet safety and regulatory hurdles remain.
Progress
44% Bias Score
Neuromarketing: Enhancing Marketing, Addressing Ethical Concerns
Neuromarketing uses brain-imaging technologies like EEG and fMRI to analyze consumer responses to marketing, enhancing campaign effectiveness and product design, but raises ethical concerns regarding data privacy, equitable access, and potential manipulation.
Neuromarketing: Enhancing Marketing, Addressing Ethical Concerns
Neuromarketing uses brain-imaging technologies like EEG and fMRI to analyze consumer responses to marketing, enhancing campaign effectiveness and product design, but raises ethical concerns regarding data privacy, equitable access, and potential manipulation.
Progress
40% Bias Score
China's Coordinated Push for Brain-Computer Interface Dominance
China's National Medical Products Administration is drafting standards for BCI medical devices, while Beijing and Shanghai aim to cultivate globally influential BCI tech leaders by 2030, reflecting a national push to transition BCI technology from exploration to implementation, with a market project...
China's Coordinated Push for Brain-Computer Interface Dominance
China's National Medical Products Administration is drafting standards for BCI medical devices, while Beijing and Shanghai aim to cultivate globally influential BCI tech leaders by 2030, reflecting a national push to transition BCI technology from exploration to implementation, with a market project...
Progress
36% Bias Score
Non-Invasive Brain-Computer Interfaces Advance at MIT
MIT's Fluid Interfaces group is pioneering non-invasive brain-computer interface (BCI) technology using AI and EEG to decode human thought processes, initially for those with motor difficulties but with potential for broader applications in areas such as vehicle control and space exploration.
Non-Invasive Brain-Computer Interfaces Advance at MIT
MIT's Fluid Interfaces group is pioneering non-invasive brain-computer interface (BCI) technology using AI and EEG to decode human thought processes, initially for those with motor difficulties but with potential for broader applications in areas such as vehicle control and space exploration.
Progress
32% Bias Score
China's NEO BCI Device to Begin Large-Scale Clinical Trials
Shanghai Neuracle Medical Technology's brain-computer interface (BCI) device, NEO, will start large-scale clinical trials next year in China, involving 30–50 patients with spinal cord injuries across approximately 10 medical centers, marking a significant step towards market approval based on succes...
China's NEO BCI Device to Begin Large-Scale Clinical Trials
Shanghai Neuracle Medical Technology's brain-computer interface (BCI) device, NEO, will start large-scale clinical trials next year in China, involving 30–50 patients with spinal cord injuries across approximately 10 medical centers, marking a significant step towards market approval based on succes...
Progress
4% Bias Score